This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Ex-Dividend Stocks With Buy Ratings

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Macy's

The retailer's stock hit a 52-week high on Thursday of $39.15.

"The 'winners are really winning' theme continues to permeate retail, and Macy's has been one of the clearest examples," Credit Suisse analysts wrote in a report Thursday. "Beginning in '10, M started gaining share in the department store space, and in the past six months, the gains have only accelerated."

Forward Annual Dividend Yield: 2.1%

Rated "A+ (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin remained about the same as last year.

Macy's has weak liquidity. Its Quick Ratio is 0.51, which demonstrates a lack of ability to meet its short-term cash needs.

In the fourth quarter, stockholders' net worth increased 7.28% from the prior year.

TheStreet Ratings' price target is $50.57. The stock closed Friday at $39.67 and has risen 23.28% year to date.






Merck

The pharmaceutical company last week reiterated its 2012 fiscal-year earnings guidance of between $3.75 and $3.85 a share.

"We see news flow for Merck accelerating in late 2012/early 2013 with several phase III readouts including odanacatib (osteoporosis), suvorexant (insomnia), Tredaptive (HPS2-THRIVE outcomes study), and extension data from the first phase III trial for anacetrapib (HDL)," JPMorgan analysts wrote in a report Thursday. "From an R&D budget standpoint, while Merck has a number of large outcomes studies currently running, the company is implementing a more disciplined approach to R&D that we believe could result in a more focused pipeline and lower expense levels over time."

Forward Annual Dividend Yield: 4.5%

Rated "A- (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin was about the same as it was last year.

Merck has average liquidity. Its Quick Ratio is 1.43, which shows the company can technically meet its short-term cash needs.

In the fourth quarter, stockholders' net worth was about the same as the previous year.

TheStreet Ratings' price target is $43.65. The stock closed Friday at $37.60 and has ticked down 10 cents year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
EMN $75.86 0.00%
LM $53.47 0.00%
KO $40.30 0.00%
M $66.45 0.00%
MRK $56.88 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs